FLC
BBOT

Fifth Lane Capital’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

Fifth Lane Capital’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$112K Buy
+10,500
New +$112K 0.14% 52